Minerva Neurosciences Inc logo

Minerva Neurosciences Inc

$ 9.76 -0.03 (-0.31%) 10:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 52.12M
Enterprise V:
$ -21.92M
Volume:
327.33K
Avg Vol (2M):
8.69M
Also Trade In:
Volume:
327.33K
Market Cap $:
52.12M
PE Ratio:
At Loss
Avg Vol (2-Month):
8.69M
Enterprise Value $:
-21.92M
PB Ratio:
0
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It primarily focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset -0.13
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score -5.48
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 64.34
9-Day RSI 58.59
14-Day RSI 58.33
6-1 Month Momentum % 20.05
12-1 Month Momentum % -23.68

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 14.68
Quick Ratio 14.68
Cash Ratio 14.59

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.1
Name Current Vs Industry Vs History
ROE % -388.19
ROA % -58.95
ROIC % -208.81
ROC (Joel Greenblatt) % -118305.41
ROCE % -54.91
Years of Profitability over Past 10-Year 1

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT 0.5
EV-to-EBITDA 0.5
EV-to-FCF 0.9
Earnings Yield (Greenblatt) % 198.65

Financials (Next Earnings Date:2022-11-08 Est.)

NERV's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:NERV

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -9.23
Beta -0.64
Volatility % 339.26
14-Day RSI 58.33
14-Day ATR ($) 1.126689
20-Day SMA ($) 9.46325
12-1 Month Momentum % -23.68
52-Week Range ($) 2.51 - 15.27
Shares Outstanding (Mil) 5.34

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Minerva Neurosciences Inc Filings

Document Form Filing Date
No Filing Data

Minerva Neurosciences Inc Analysis

Share your research

Headlines

See More
No news.